Previous 10 | Next 10 |
Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral neuromodulation (“SNM”) device, today announced that it has entered into an exclusive agreement to supply the Axoni...
One-year Pivotal Study Results from ARTISAN-SNM to be Presented at Plenary Session Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the...
Axonics Modulation Technologies (NASDAQ: AXNX ) revealed on Monday (September 9) that the US Food and Drug Administration has given the company seal of approval for its rechargeable sacral neuromodulation (SNM) device. Called the Axonics r-SNM® System, the rechargeable devic...
Company to host conference call and webcast at 9:00 am EDT Today Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral neuromodulation (“SNM”) device for the t...
Nuvectra Corporation (NASDAQ: NVTR ) is a medical device company founded in 2008 that went public in March 2016. NVTR’s flagship product, Algovita, is a neurostimulator that is FDA approved for the treatment of chronic pain of the trunk (human torso) and limbs (reimbursable under exis...
Correvio Pharma (NASDAQ: CORV ) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald. More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...
Axonics Modulation Technologies, Inc. (AXNX) Q2 2019 Results Earnings Conference Call August 05, 2019, 4:30 pm ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - Presi...
Axonics Modulation Technologies (NASDAQ: AXNX ): Q2 GAAP EPS of -$0.68 misses by $0.19 . More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, reported today financial results for the sec...
AEIS , AEL , ANSS , APLE , APU , ATSG , AVID , AWR , AXNX , BHF , BKD , BKH , BWXT , CAR , CBPO , CBT , CDEV , CLR , COHU , CSOD , CXW , CYH , CZR , DEI , DIOD , DOOR , DRH , EVBG , FRPT , FRTA , GPRE , HIIQ , HLIO , HPR , IFF , IPAR , ITRI , IVC , KLA...
News, Short Squeeze, Breakout and More Instantly...
Axonics Modulation Technologies Inc. Company Name:
AXNX Stock Symbol:
NASDAQ Market:
Axonics Modulation Technologies Inc. Website:
Axonics, Inc. (NASDAQ: AXNX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.09% on the day to $68.5. Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulat...
Generated record revenue, gross margin and net income in 2Q24 Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results f...
Viridien ADR (CGGYD) is expected to report for Q2 2024 Civitas Resources Inc. (CIVI) is expected to report $2.9 for Q2 2024 Aptiv PLC (APTV) is expected to report $1.37 for Q2 2024 Ardelyx Inc. (ARDX) is expected to report $-0.1 for Q2 2024 Beazer Homes USA Inc. (BZH) is expected ...